a public good project by the
Synthesis
Company
of California

© 2026

Relaxin drives Wnt signaling through upregulation of PCDHY in prostate cancer | doi.page

0 citations0 references

Google Scholar doi.org

Relaxin drives Wnt signaling through upregulation of PCDHY in prostate cancer

The Prostate·2010·Vol. 70(10), pp. 1134–1145

Citations Over TimeTop 12% of 2010 papers

Vanessa C. Thompson, Antonio Hurtado‐Coll, Dmitry Turbin, Ladan Fazli, Melanie Lehman, Martin Gleave, Colleen C. Nelson

Abstract

These data suggest that prostate cancer cell motility and altered androgen receptor activity attributed to relaxin may be mediated in part by Wnt11.

Related Papers

→ Physiology and Molecular Biology of the Relaxin Peptide Family(2006)88 cited
→ Relaxin Used to Produce the Cervical Ripening of Labor(1995)14 cited
→ Relaxin(1984)25 cited
→ Relaxins(2015)1 cited
→ Regulation of Relaxin Secretion(1966)6 cited